Please sign in to follow a disease.
Biofrontera Inc.
Clinical trials sponsored by Biofrontera Inc., explained in plain language.
A biopharmaceutical company focused on dermatological treatments, including photodynamic therapy for skin conditions.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New light therapy could zap precancerous skin spots on Hard-to-Treat areas
Disease control CompletedThis study tests a gel (Ameluz®) plus red light therapy for actinic keratosis, rough precancerous patches on skin. It includes 172 adults with 4-15 spots on arms, legs, neck, or trunk. The goal is to see if the treatment clears these spots better than a placebo gel.
Phase 3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New light therapy could zap stubborn acne without pills
Disease control CompletedThis study tests a treatment called photodynamic therapy (PDT) for adults with moderate to severe acne. A gel called Ameluz® is applied to the face, then activated with a special red light. The goal is to see if this combination reduces acne lesions better than a placebo. About 1…
Phase 2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC